Heron Therapeutics, Inc. (HRTX) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Heron Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:06.018 Thank you for standing by. Welcome to the Heron Therapeutics Q3 2025 00:00:06.018 -- 00:00:10.603 conference call. At this time, all participants are in listen-only mode. 00:00:10.603 -- 00:00:14.488 After the speaker's presentation, there will be a question and answer session. 00:00:14.488 -- 00:00:19.073 To ask a question during this session, you will need to press star 1 and 1 on your telephone. 00:00:19.073 -- 00:00:23.458 You will then hear an automated message advising your hand is raised. 00:00:23.458 -- 00:00:26.882 To withdraw your question, please press star 1 and 1 again. 00:00:26.882 -- 00:00:30.338 Please be advised that today's conference is being recorded. 00:00:30.338 -- 00:00:34.284 I would now like to hand the conference over to your first speaker today, Melissa Jarrell, 00:00:34.284 -- 00:00:38.407 Executive Director of Legal. Please go ahead. 00:00:39.271 -- 00:00:43.738 Thank you, Operator, and hello, everyone. Thank you for joining us on the Heron Therapeutics 00:00:43.738 -- 00:00:47.764 conference call today to discuss the company's financial results for the quarter ended 00:00:47.764 -- 00:00:50.147 September 30th, 2025. 00:00:50.147 -- 00:00:55.074 With me today from Heron are Craig Collard, Chief Executive Officer, Ira Duarte, Executive 00:00:55.074 -- 00:00:59.597 Vice President, Chief Financial Officer, Bill Forbes, Executive Vice President, Chief 00:00:59.597 -- 00:01:04.525 Development Officer, Mark Hensley, Chief Operating Officer, and Kevin Warner, Senior 00:01:04.525 -- 00:01:07.570 Vice President, Medical Affairs Strategy and Engagement. 00:01:07.570 -- 00:01:11.937 For those of you participating via conference call, slides are made available via webcast 00:01:11.937 -- 00:01:16.264 and can also b...